Global Wound Management Market to Reach Nearly $13 Billion, New Report from MedMarket Diligence

Jan. 9, 2013 - PRLog -- Despite limitations to growth of wound care products stemming from reimbursement and regulatory approval of more advanced products, the global wound management market is growing steadily as a result of improved, cost-effective products addressing the upward trending caseload of otherwise costly slow-healing wounds. The result is that sales of wound management products have grown and will continue to grow at a sustainable rate for the next decade.

"Wound care is a medtech market that focuses the attention of manufacturers on continually applying insights in wound etiology to products that exploit the body's natural healing processes to accelerate wound healing," says Patrick Driscoll of MedMarket Diligence, publisher of a new global report on wound management. "This has driven the development of a wide range of dressing types with novel materials, advanced physical wound healing technologies and bioengineered skin."

Underlying most wound care growth is the demographics of an aging population and the growing incidences of chronic diseases, which impede the healing process due to their involvement in a number of bodily functions. Illnesses that cause the most significant problems include diabetes, chronic obstructive pulmonary disease (COPD), arteriosclerosis, peripheral vascular disease (PVD), heart disease, and any conditions leading to hypotension, hypovolemia, edema, and anemia. While chronic diseases are more frequent in the elderly, wound healing will be delayed in any patient with underlying illness. While most wounds heal without any problems, chronic wounds may take months or years to fully close, or may never close. Chronic wounds adversely affect the individual’s quality of life, and are a leading cause of burgeoning healthcare costs.

The new MedMarket Diligence report is entitled, "Worldwide Wound Management, Forecast to 2020: Established and Emerging Products, Technologies and Markets in the Americas, Europe, Asia/Pacific and Rest of World". The report details the complete range of products and technologies used in wound management and wound care, from dressings, bandages, hydrogels, skin and skin substitutes, negative pressure wound therapy (NPWT) and others. The report details the current clinical and technology developments in the worldwide market providing a current assessment of products in development and on the market; market size and forecast; competitor market shares; 52 key competitor profiles; and an assessment of the market opportunity for current and hopeful competitors. The report provides full year (actual) 2011 market size and share data, with forecast market data to 2020, for the Americas (with detail for U.S., Rest of North America and Latin America), Europe (with detail for United Kingdom, Germany, France, Spain, Italy, and Rest of Europe), Asia/Pacific (with detail for Japan, Korea and Rest of Asia/Pacific) and Rest of World.

This report's emphasis is on advanced and leading edge developments (i.e., those approaching wound management from novel perspective) such as growth factors, stem cells, gene therapy and other approaches, while baseline data (current and forecast market size and current competitor market shares) is provided for established segments -- multiple dressings types (film, foam, alginate, antibacterial, non-adherent), hydrogels, hydrocolloids, and NPWT. The report details the clinical and technology developments underlying the clinical practice and market development in wound care market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor data are presented for the U.S., leading western European countries, Japan and the Rest of World category. The report’s company profiles assess key companies regarding current/projected products, technologies and positions in the advanced wound care market.  

The wound care market is dominated by Johnson and Johnson, 3M, Smith & Nephew, and Systagenix, but is also driven by a large number of mid-size and smaller companies effectively pursuing niches in the market.

The report is described in detail at http://www.mediligence.com/rpt/rpt-s249.htm.

The report may be purchased online for immediate download from https://www.mediligence.com/store/page44.html.

For other MedMarket Diligence reports, see http://www.mediligence.com.

[MedMarket Diligence Reports are produced through primary and secondary research. Data is gathered from published sources on products and technologies on the market and under development.  Clinicians and industry representatives are interviewed for their knowledge and insights on product development, market development, clinical practice and trends associated with the evolving use of technologies. Secondary data is used to corroborate and support assessments and projections.  Reports are written and researched by industry insiders, whose familiarity with the companies, industry dynamics and other marketplace specifics facilitate the research process and ensure high quality and thorough reports.]